R&D diabetes news – Q2 2020

Table of Content Diabetes

Q2 2020 Reporting

Each quarter, I redact a summary of the R&D news in diabetes and some related diseases as obesity & NASH, both for drugs and devices that include updated R&D pipelines of selected companies, detailed recent clinical results, and regulatory and business news.

This quarter report includes the main results presented during the 2020 ADA conference and a specific focus on recent results of advanced clinical trials in NASH

You can have access to this report on demand by filling this short form:

Share Post
Share on facebook
Share on linkedin
Share on twitter
Share on pinterest
Share on email